MARKER THERAPEUTICS, INC.: cashflow_financing
| Value | {"amount": -25000, "concept": "us-gaap:NetCashProvidedByUsedInFinancingActivities", "currency": "USD"} |
|---|---|
| Period | 2016-01-01 – 2016-06-30 |
| Status | current |
| Entity | MARKER THERAPEUTICS, INC. |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T10:54:30.727303+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/c468c5e6-a0fb-4ae1-82b9-c269b70e81ab
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001193125-16-682054Retrieved: 2026-08-19T10:54:30.727303+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0001094038/cashflow-financing/2016-06-30 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/c468c5e6-a0fb-4ae1-82b9-c269b70e81ab
History
- no predecessors — first report